Steven Cohen’s Novavax NVAX Stock Holding History

Steven Cohen’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.26M	Sell	664,286 -853,925	-56%	-$7.65M	0.01%	1611
2026 Q1	$12.4M	Buy	1,518,211 +1,501,776	+9,138%	+$13.6M	0.02%	1097
2025 Q4	$110K	Sell	16,435 -80,482	-83%	-$607K	﹤0.01%	3727
2025 Q3	$840K	Buy	+96,917	New	+$754K	﹤0.01%	1758
2023 Q3	–	Sell	-3,194	Closed	-$25.5K	–	2753
2023 Q2	$23.7K	Buy	+3,194	New	+$25.1K	﹤0.01%	1756
2022 Q3	–	Sell	-500	Closed	-$26K	–	1642
2022 Q2	$26K	Buy	+500	New	+$25.9K	﹤0.01%	1331
2021 Q2	–	Sell	-83,800	Closed	-$15.2M	–	1108
2021 Q1	$15.2M	Buy	83,800 +20,400	+32%	+$4.07M	0.07%	325
2020 Q4	$7.07M	Sell	63,400 -534,019	-89%	-$56.8M	0.03%	521
2020 Q3	$64.7M	Buy	+597,419	New	+$72.8M	0.33%	71
2016 Q1	–	Sell	-19,215	Closed	-$3.22M	–	808
2015 Q4	$3.22M	Buy	+19,215	New	+$2.96M	0.03%	480
2015 Q2	–	Sell	-4,750	Closed	-$786K	–	809
2015 Q1	$786K	Buy	+4,750	New	+$771K	0.01%	630

Other funds holding NVAX

SCM

Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Steven Cohen's NVAX Position: Q2 2026 in Review

Steven Cohen reduced its Novavax (NVAX) stake by 56% in Q2 2026, selling an estimated $7.65M and leaving 664,286 shares worth $6.26M. The position accounts for 0.01% of the portfolio, ranked #1611.

Steven Cohen first reported a position in NVAX in Q1 2015 and has held it in 11 quarters since. The position peaked at $64.7M in Q3 2020. 264 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

Steven Cohen held 664,286 shares of Novavax worth $6.26M as of Q2 2026.
Steven Cohen sold 853,925 Novavax shares in Q2 2026, an estimated $7.65M.
Novavax made up 0.01% of Steven Cohen's portfolio in Q2 2026, its #1611 holding.
Steven Cohen first reported a position in Novavax in Q1 2015 and has held it in 11 quarters since.
Steven Cohen's Novavax position peaked at $64.7M in Q3 2020.
264 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.